Siegfried Holding AG
SFZN
Classificação em ações
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Preço da ação
$88.34
Valor de mercado
$3.87B
Variação (1 dia)
1.68%
Variação (1 ano)
-12.97%
País
CH
Negociar Siegfried Holding AG (SFZN)
Categoria
Healthcare
Receita da Siegfried Holding AG (SFZN)
Receita em Oct 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Siegfried Holding AG, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Siegfried Holding AG de 2002 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2025 | $1.67B | 16.75% |
| 2024 | $1.43B | -5.21% |
| 2023 | $1.51B | 13.69% |
| 2022 | $1.33B | 9.98% |
| 2021 | $1.21B | 28.54% |
| 2020 | $940.74M | 9.18% |
| 2019 | $861.60M | 6.71% |
| 2018 | $807.42M | 4.86% |
| 2017 | $770.00M | 9.19% |
| 2016 | $705.17M | 46.67% |
| 2015 | $480.78M | 51.48% |
| 2014 | $317.39M | -24.47% |
| 2013 | $420.19M | 4.56% |
| 2012 | $401.86M | 15.06% |
| 2011 | $349.27M | 3.82% |
| 2010 | $336.43M | 22.82% |
| 2009 | $273.92M | 1.32% |
| 2008 | $270.33M | -4.00% |
| 2007 | $281.59M | 14.52% |
| 2006 | $245.88M | 1.65% |
| 2005 | $241.89M | -14.43% |
| 2004 | $282.67M | -4.53% |
| 2003 | $296.08M | 2.63% |
| 2002 | $288.49M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
